Status:
COMPLETED
Effect of Surgical Therapy on RANKL/OPG (Osteoprotegerin) System
Lead Sponsor:
Hacettepe University
Conditions:
Chronic Periodontitis
Aggressive Periodontitis
Eligibility:
All Genders
18-70 years
Brief Summary
In the present clinical study including chronic, aggressive periodontitis and healthy individuals, the investigators aimed to determine the RANKL, osteoprotegrin (OPG), Interleukin-1 (IL-1β), IL-10, I...
Eligibility Criteria
Inclusion
- Chronic periodontitis having at least 5mm or more probing depth and aggressive periodontitis patients.
Exclusion
- Any known systemic disorder, used antibiotics and/or anti-inflammatory medications, had periodontal treatment in the last 3 months and all of them were non smokers. Subjects who were lactating and pregnant were also excluded.
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT02190773
Start Date
January 1 2010
End Date
April 1 2013
Last Update
July 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Ankara, Turkey (Türkiye), 06100